Dietrich John Pauls - Jun 23, 2023 Form 4 Insider Report for DiaMedica Therapeutics Inc. (DMAC)

Role
President and CEO, Director
Signature
/s/ Amy E. Culbert, attorney-in-fact
Stock symbol
DMAC
Transactions as of
Jun 23, 2023
Transactions value $
$49,997
Form type
4
Date filed
6/26/2023, 04:34 PM
Previous filing
Jun 2, 2023
Next filing
Jun 3, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DMAC Voting Common Shares, no par value per share Purchase $50K +12.8K +22.91% $3.91 68.6K Jun 23, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 1,749 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan.